Heart failure & cardiomyopathies

Socio-Economic Status and the Effect of Guideline-Directed Medical Therapy in the STRONG-HF Study

ESC Heart FailPublished post hoc analysis of the STRONG-HF study

Authors' conclusion

In this post hoc analysis of the STRONG-HF study, lower SES was associated with milder acute HF but similar 180-day outcomes. Higher SES patients benefitted more from HIC.

Study context

Population
Patients with acute heart failure (AHF), by socio-economic status (SES) measured by annual household income, years of education and medical insurance coverage
Comparison
Patients' baseline characteristics, outcomes (HF readmission, death and their composite) and the effect of high-intensity care (HIC) vs. usual care (UC) were examined by SES scores 0-2, 3 and 4-5

Primary result

As reported in the abstract

Baseline characteristics by SES · before discharge
  • Lower SES patients were younger, predominantly female, Black and non-European, had fewer comorbidities such as atrial fibrillation, diabetes and ischaemic heart disease and exhibited milder HF (lower NYHA class, lower creatinine and higher cholesterol before discharge)

Further findings

OutcomeHR (95% CI)
HF readmission or death · 180-daySES scores 3vs SES scores 0-2After adjusting for baseline characteristics · differences were not statistically significant0.75 (0.48–1.16)
HF readmission or death · 180-daySES scores 4-5vs SES scores 0-2After adjusting for baseline characteristics · differences were not statistically significant0.85 (0.58–1.23)

HR

OutcomeSES scores 0-2SES scores 3SES scores 4-5
Treatment effect of HIC by SES0.690.720.50
  • Treatment effect of HIC by SES: Higher SES patients had numerically better treatment effect from HIC

Original publication

Socio-Economic Status and the Effect of Guideline-Directed Medical Therapy in the STRONG-HF Study. ESC Heart Fail. Published 12 February 2025. doi:10.1002/ehf2.15156

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.